Dr. Jae Park is a leukemia specialist and Director of the Adult ALL Program at Memorial Sloan Kettering Cancer Center. He is internationally recognized for his work in CAR T-cell therapy and other emerging treatments for blood cancers. His research focuses on improving therapies for patients with ALL through clinical trials and innovative immunotherapies.